SEC Tracker
Get the app

Pacira BioSciences PCRX

Pacira BioSciences agrees to $36.50 per share acquisition

Form
8-K
Filed
Importance
Major
  1. Entered into a merger agreement with Viatris Inc. on Oct 8, 2026
  2. Tender offer to acquire all outstanding shares at $36.50 per share
  3. Merger to be completed after tender offer, with no shareholder vote required

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pacira BioSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  3. Geron GERN public float $861M, Jun 30, 2025
  4. Anaptysbio ANAB public float $633M, Dec 31, 2025
  5. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025